Greenberg RE - Search Results

1

Accelerated methotrexate, vinblastine, doxorubicin, and cisplatin is safe, effective, and efficient neoadjuvant treatment for muscle-invasive bladder cancer: results of a multicenter phase II study with molecular correlates of response and toxicity.

Plimack ER, Hoffman-Censits JH, Viterbo R, Trabulsi EJ, Ross EA, Greenberg RE, Chen DY, Lallas CD, Wong YN, Lin J, Kutikov A, Dotan E, Brennan TA, Palma N, Dulaimi E, Mehrazin R, Boorjian SA, Kelly WK, Uzzo RG, Hudes GR. Plimack ER, et al. Among authors: greenberg re. J Clin Oncol. 2014 Jun 20;32(18):1895-901. doi: 10.1200/JCO.2013.53.2465. Epub 2014 May 12. J Clin Oncol. 2014. PMID: 24821881 Free PMC article. Clinical Trial.

2

Phase II study of estramustine and vinblastine, two microtubule inhibitors, in hormone-refractory prostate cancer.

Hudes GR, Greenberg R, Krigel RL, Fox S, Scher R, Litwin S, Watts P, Speicher L, Tew K, Comis R. Hudes GR, et al. J Clin Oncol. 1992 Nov;10(11):1754-61. doi: 10.1200/JCO.1992.10.11.1754. J Clin Oncol. 1992. PMID: 1383436 Clinical Trial.

3

Paclitaxel plus estramustine in metastatic hormone-refractory prostate cancer.

Hudes GR, Nathan FE, Khater C, Greenberg R, Gomella L, Stern C, McAleer C. Hudes GR, et al. Semin Oncol. 1995 Oct;22(5 Suppl 12):41-5. Semin Oncol. 1995. PMID: 7481860 Clinical Trial.

4

Phase I study of paclitaxel and estramustine: preliminary activity in hormone-refractory prostate cancer.

Hudes GR, Obasaju C, Chapman A, Gallo J, McAleer C, Greenberg R. Hudes GR, et al. Semin Oncol. 1995 Jun;22(3 Suppl 6):6-11. Semin Oncol. 1995. PMID: 7597435 Clinical Trial.

5

Phase II study of topotecan in metastatic hormone-refractory prostate cancer.

Hudes GR, Kosierowski R, Greenberg R, Ramsey HE, Fox SC, Ozols RF, McAleer CA, Giantonio BJ. Hudes GR, et al. Invest New Drugs. 1995;13(3):235-40. doi: 10.1007/BF00873806. Invest New Drugs. 1995. PMID: 8729952 Clinical Trial.

6

Phase II trial of 96-hour paclitaxel plus oral estramustine phosphate in metastatic hormone-refractory prostate cancer.

Hudes GR, Nathan F, Khater C, Haas N, Cornfield M, Giantonio B, Greenberg R, Gomella L, Litwin S, Ross E, Roethke S, McAleer C. Hudes GR, et al. J Clin Oncol. 1997 Sep;15(9):3156-63. doi: 10.1200/JCO.1997.15.9.3156. J Clin Oncol. 1997. PMID: 9294479 Clinical Trial.

7

Tirapazamine with cisplatin in patients with advanced non-small-cell lung cancer: a phase II study.

Treat J, Johnson E, Langer C, Belani C, Haynes B, Greenberg R, Rodriquez R, Drobins P, Miller W Jr, Meehan L, McKeon A, Devin J, von Roemeling R, Viallet J. Treat J, et al. J Clin Oncol. 1998 Nov;16(11):3524-7. doi: 10.1200/JCO.1998.16.11.3524. J Clin Oncol. 1998. PMID: 9817270 Clinical Trial.

8

Maintenance therapy for superficial bladder cancer.

Baselli EC, Greenberg RE. Baselli EC, et al. Among authors: greenberg re. Oncology (Williston Park). 2001 Jan;15(1):85-8; discussion 88-91. Oncology (Williston Park). 2001. PMID: 11271984 Review.

9

Hypoxia in human prostate carcinoma: an Eppendorf PO2 study.

Movsas B, Chapman JD, Hanlon AL, Horwitz EM, Pinover WH, Greenberg RE, Stobbe C, Hanks GE. Movsas B, et al. Among authors: greenberg re. Am J Clin Oncol. 2001 Oct;24(5):458-61. doi: 10.1097/00000421-200110000-00009. Am J Clin Oncol. 2001. PMID: 11586096

10

Decision-making strategies for patients with localized prostate cancer.

Diefenbach MA, Dorsey J, Uzzo RG, Hanks GE, Greenberg RE, Horwitz E, Newton F, Engstrom PF. Diefenbach MA, et al. Among authors: greenberg re. Semin Urol Oncol. 2002 Feb;20(1):55-62. doi: 10.1053/suro.2002.30399. Semin Urol Oncol. 2002. PMID: 11828358

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

209 results

Search Page